CellCept Side Effects: What to Expect and When to Call Your Doctor

CellCept (mycophenolate mofetil) is a powerful immunosuppressant that comes with a real and significant side effect profile. Understanding what to expect — and knowing which symptoms require immediate medical attention — is one of the most important parts of managing life on this medication.

This guide covers CellCept's boxed warnings, common side effects, serious risks, and key signs that should prompt a call to your transplant team.

Boxed Warnings: The Most Serious Risks

The FDA requires CellCept to carry a boxed warning (the most serious warning level) for three categories of risk:

Embryofetal toxicity: CellCept is associated with a high risk of first-trimester miscarriage and serious birth defects (including malformations of the ears, face, heart, and limbs). Women who can become pregnant must use two forms of contraception during treatment and for 6 weeks after stopping. Negative pregnancy tests are required before starting and 8–10 days later.

Malignancies: Patients taking CellCept have an increased risk of developing lymphoma and other cancers, particularly skin cancer. Immunosuppression allows abnormal cells that would normally be cleared by the immune system to proliferate. Minimize sun exposure, use SPF 30+ sunscreen, and have regular skin checks.

Serious infections: By suppressing the immune system, CellCept makes patients more vulnerable to bacterial, viral, and fungal infections — including opportunistic infections that would not normally cause illness in healthy people. CMV, BK virus, and Pneumocystis pneumonia (PCP) are particularly relevant for transplant patients.

Common Side Effects (Affecting More Than 1 in 10 Patients)

GI side effects are the most common complaint with CellCept, particularly in the first weeks of treatment:

Nausea and vomiting

Diarrhea (can be significant — inform your transplant team if severe or persistent)

Stomach pain and cramping

Constipation

Headache

Dizziness

Insomnia

Tremors (particularly in patients also taking tacrolimus)

Rash

If GI side effects are severe and interfering with your ability to take CellCept consistently, talk to your transplant team. Switching to Myfortic (mycophenolate sodium delayed-release) may reduce GI symptoms in some patients because the drug is released in the intestine rather than the stomach.

Serious Side Effects That Require Immediate Medical Attention

Signs of serious infection: High fever, shaking chills, severe cough with phlegm, shortness of breath, painful urination, worsening fatigue, or unusual rash. Do not wait to see if symptoms improve.

PML (Progressive Multifocal Leukoencephalopathy): A rare but serious brain infection caused by JC virus. Symptoms include confusion, problems with speech, vision changes, and weakness or coordination problems that develop gradually but worsen rapidly. This is a medical emergency.

Blood disorders: Easy bruising, unusual bleeding, extreme fatigue, or pallor can indicate low white blood cells (neutropenia), low platelets (thrombocytopenia), or anemia. Regular blood counts (CBC) are required while on CellCept.

Signs of cancer: Unexplained weight loss, fever, night sweats, swollen lymph nodes, or new skin lesions (particularly dark, irregular-bordered spots). Annual skin cancer screening is recommended for transplant patients.

Severe allergic reaction: Hives, difficulty breathing, swelling of the face, lips, tongue, or throat. Call 911 immediately.

Blood Monitoring: What to Expect

Regular laboratory monitoring is required while taking CellCept. Your transplant team will typically check:

Complete blood count (CBC) — to monitor for neutropenia, thrombocytopenia, and anemia

Liver function tests (LFTs) — mycophenolate can affect liver enzymes

Kidney function (creatinine, BUN) — especially important for detecting BK virus nephropathy

Viral monitoring (CMV, BK virus in transplant patients)

CellCept and Pregnancy: Critical Information

CellCept must not be taken during pregnancy. Women of childbearing potential must use two forms of contraception: hormonal contraception alone is not sufficient because CellCept can reduce the effectiveness of oral birth control pills. A second non-hormonal method (condom, diaphragm, IUD) is required simultaneously.

Men taking CellCept should use condoms during treatment and for 90 days after the last dose if their female partner could become pregnant.

For a complete overview of drug interactions with CellCept, see: CellCept Drug Interactions: What to Avoid and What to Tell Your Doctor.